Immunic Presents New Clinical, Biomarker, and Preclinical Data for Vidofludimus Calcium in Four Poster Presentations at MSToronto2026 - the 10th Joint ACTRIMS-ECTRIMS Meeting
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street lower on AI spending jitters; oil prices rebound
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Brent hits five-month high on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| (NASDAQ: IMUX) | Delayed: 7.37 -0.11 (1.47%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.48 | 52 Week High | $ | |||
| Open | $7.50 | 52 Week Low | $ | |||
| Day High | $7.70 | P/E | N/A | |||
| Day Low | $7.16 | EPS | $ | |||
| Volume | 131,101 | |||||
